Clinical Trials Browser

Completed × Recurrence × Panobinostat × Clear all

NCT02654990 2024-07-12

PANORAMA_3

Phase 2 Completed

248 enrolled 28 charts

Multiple Myeloma, Recurrence

NCT00936611 2021-01-28

LBH589 in Relapsed or Relapsed and Refractory Waldenstrom's Macroglobulinemia

Phase 2 Completed

39 enrolled 13 charts

Waldenstrom Macroglobulinemia, Recurrence

NCT01023308 2020-03-17

PANORAMA-1

Phase 3 Completed

767 enrolled 17 charts

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

NCT02290431 2019-11-18

Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed/Refractory Multiple Myeloma

Phase 2 Completed

31 enrolled 19 charts

Multiple Myeloma, Recurrence

NCT01083602 2017-12-21

MACS1271

Phase 2 Completed

55 enrolled 11 charts

Multiple Myeloma, Recurrence

NCT01321346 2015-11-24

A Study Of Panobinostat In Children With Refractory Hematologic Malignancies

Phase 1 Completed

LymphoidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Leukemia, Myeloid, Lymphoma, Lymphoma, Non-Hodgkin, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00967044 2015-02-26

Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma

Phase 1/2 Completed

31 enrolled 6 charts

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Recurrence